Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in the USA / NCT06264518
Starting soon Observational

An Observational Exploration of Clinical Trials Targeting Traumatic Brain Injury

NCT06264518 · tracked via the Priya Life Science USA tracker
Sponsor
Power Life Sciences Inc
Phase
Observational
Started
2025-03
Last updated
2024-02-20

Condition(s) studied

Traumatic Brain Injury

Study summary

Clinical study participation has historically been heavily biased toward specific demographics.

Several people will be invited to enroll in this study so that it may collect a variety of data about traumatic brain injury clinical trial experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal.

People with traumatic brain injury who are invited to take part in medical research will benefit from the analysis of the data.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient has been diagnosed with traumatic brain injury * Patient has self-identified as planning to enroll in an observational clinical trial * Patient is a minimum of 18 years or older Exclusion Criteria: * Pregnant or nursing patients * Inability to perform regular electronic reporting * Patient does not understand, sign, and return consent form

Primary outcome measure(s)

  • Number of patients who decide to enroll in a traumatic brain injury clinical trial — 3 months
  • Rate of patients who remain in traumatic brain injury clinical trial to trial completion — 12 months

Trial sites (1)

FacilityCityRegionStatus
Power Life Sciences San Francisco California

More Power Life Sciences Inc. trials in the USA

Investigative Analysis of Soft Tissue Sarcoma Clinical Trials: An Observational Study Starting soon
Revealing Engagement Patterns Among Hepatic Encephalopathy Patients Starting soon
Understanding Patient Engagement Trends in Anxiety Disorder Clinical Research Starting soon
Assessing Patient Engagement in Keratoconus Clinical Research Starting soon
Exploring Acne Treatments Through Clinical Research Participation Starting soon

Other trials for the same condition

Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury Recruiting
Aerobic Exercise After Traumatic Brain Injury Enrolling by invitation
Study to Assess the Safety of Amantadine Hydrochloride (HCl) Intravenous (IV) Solution (MR-301) in Patients With Severe Traumatic Brain Injury (TBI). Active, not recruiting
Traumatic Brain Injury and Stroke Long Term Outcome Recruiting
CoMind Early Feasibility Study Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06264518 on ClinicalTrials.gov ↗ ← All trials in the USA